You are here

Article Text

Article menu
Download PDFPDF
Editorial commentary
The outcome of depressive disorders in the setting of neurological illness
  1. H Rickards
  1. Department on Neuropsychiatry, Queen Elizabeth Psychiatric Hospital, Mindelsohn Way, Edgbaston, Birmingham B15 2QZ, UK; hugh.rickards@sbmht.wmids.nhs.uk

    https://doi.org/10.1136/jnnp.74.7.842-a

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

      Depression is a common and disabling feature in neurological outpatients

      The depressions are a heterogeneous group of conditions. This is particularly true when depressive symptoms are experienced in the setting of coarse brain disease. Here the clinical presentation, differential diagnosis, and aetiology offer unique challenges to the clinician. The development of broader, more patient centred outcome measures such as quality of life and “health gain” has also elevated the status of depression, particularly because depressive symptoms are now seen to be the primary contributors to morbidity in some neurological illnesses. Two recent studies showed how depressive symptoms accounted for much more of the variance in morbidity in Parkinson’s disease (40%) than did movement disorder (17%).1,2 Critics of these studies could rightly point out that before the advent of L-dopa, motor disorder was definitely the biggest contributor to morbidity in Parkinson’s disease, and that quality of life as a measure is more directly related to mood state …

      View Full Text

      Linked Articles